Prime Medicine (PRME) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order by the CEO, welcoming stockholders and outlining the agenda in accordance with bylaws and Delaware law.

• Directors, executive team members, and audit firm representatives were introduced.

• Rules of conduct and procedures for voting and questions were explained, with a limit of two questions per stockholder.

Board and executive committee updates

• Two nominees, Michael Kelly and David Schenkein, were presented for election as Class I Directors for a three-year term.

• No advance notice of alternative nominations was received.

Corporate governance

• The appointment of PricewaterhouseCoopers as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was submitted for stockholder ratification as a governance measure.

• The audit committee, composed entirely of independent directors, made the appointment.